Upon administration of the extracellular CTSD inhibitor, we observed that HFD-fed rats showed a significant reduction in plasma insulin levels and improvement of steatosis, two important characteristics of diet-induced NAFLD. The gene discussed is CTSD; the disease is metabolic dysfunction-associated steatotic liver disease.